Best Alzheimer's disease Treatment Clinics and Prices in India for Australians

India recently approved Lormalzi (donanemab). This is the first disease-modifying drug targeting the root cause of Alzheimer's. This intravenous therapy clears amyloid-beta plaques from the brain. It is for early-stage patients. Treatment may slow cognitive decline by roughly 30%.

• Targeted action: Intravenous monoclonal antibodies identify and clear amyloid protein deposits.
• Eligibility criteria: Treatment is restricted to adults with confirmed early-stage symptomatic Alzheimer's.
• Diagnostic requirements: Patients must show plaque evidence via PET-CT or CSF analysis.
• Monitoring protocols: Frequent MRI scans check for brain swelling or microbleeds during treatment.

Bookimed Expert Insight: Major Indian medical hubs like Delhi, Mumbai, and Bengaluru offer specialised diagnostics. Specialist centres such as Manipal Hospitals serve over 2,000,000 patients annually. New drugs like Lormalzi are emerging. These high-volume centres provide the PET-CT imaging and neurologists needed to safely monitor such therapies.

Patient Consensus: Patients in India emphasise that care focus remains on specialist evaluations and accurate diagnostics. They recommend requesting peer-reviewed evidence when discussing disease-modifying therapies. This helps distinguish between symptom control and actual reversal.

Neurologists in India standardly prescribe acetylcholinesterase inhibitors and NMDA receptor antagonists to manage Alzheimer's symptoms. These protocols align with international standards to treat cognitive decline. Specialists often use combination therapies like Donepezil and Memantine. These drugs help maintain patient independence and memory functions.

• Cognitive enhancers: Doctors frequently prescribe Donepezil or Rivastigmine for mild-to-moderate memory loss.
• NMDA antagonists: Memantine is a standard choice for moderate-to-severe stages to regulate glutamate activity.
• Combination tablets: Clinicians use fixed-dose options like Donamem to reduce the pill burden.
• Behavioural management: Specialists prescribe low-dose antipsychotics or antidepressants to handle aggression, anxiety, or insomnia.

Bookimed Expert Insight: Indian tertiary centres like Manipal Hospitals and Apollo Hospital Indraprastha see over 1,000,000 patients annually. This high volume allows neurologists to refine complex drug protocols for cases. While oral medications are standard, some facilities also offer stem cell therapy for Alzheimer's starting from A$8,900. JCI-accredited clinics in Mumbai and Delhi provide specialists who focus on these multi-modal treatment plans.

India offers dedicated long-term residential dementia care through specialised memory care homes. These private facilities provide 24/7 medical supervision and secure environments. They manage late-stage symptoms and wandering risks. Most centres operate in metropolitan hubs like Bengaluru, Pune, and New Delhi.

• Specialised safety: Secured perimeters and surveillance prevent spatial disorientation and wandering.
• Cognitive therapy: Brain-mapping games and memory recall routines help slow symptoms.
• Medical teams: Facilities staff on-site nursing and visiting neuro-geriatricians for care.
• Nutritional support: Dietary plans manage appetite loss or swallowing difficulties in patients.

Bookimed Expert Insight: Dedicated dementia care in India is often concentrated in high-demand hubs. The Nightingales Centre in Bengaluru is one of the largest specialised hubs. Moving to centres in these cities ensures access to trained neuro-geriatricians. These specialists are less common in smaller Indian regional areas.

Patient Consensus: Families note that secured residential homes in India provide peace of mind. They appreciate the structured daily memory routines and the constant nursing presence. Many find the specialised dietary support essential for late-stage care.

Ayurvedic clinics in India offer clinical management for Alzheimer's disease. These treatments focus on slowing cognitive decline and improving quality of life. Indian centres use specialised Panchakarma detoxification, Shirodhara oil therapies, and neuroprotective herbs like Brahmi. These protocols aim to manage behavioural symptoms alongside conventional neurology.

• Detoxification protocols: Clinicians use supervised Panchakarma to remove metabolic toxins and balance nervous system function.
• Nootropic formulations: Physicians prescribe Medhya Rasayana herbs, including Ashwagandha and Mandookaparni, to support neurogenesis.
• Nasal administration: Nasya therapy delivers medicated oils via nasal passages to target the head region.
• Integrative centres: Facilities like AUM Integrated Medicine & Wellness Centre combine internal medicine with Ayurveda.

Bookimed Expert Insight: Bookimed data shows a shift towards integrative care. Modern diagnostics now meet traditional protocols. Dr Prayag Pandya at AUM Integrated Medicine combines MD-level internal medicine with supervised Panchakarma. This hybrid approach allows for medical monitoring during 7 to 21-day intensive Ayurvedic programmes.

Patient Consensus: Patients in India often report that Ayurveda does not reverse cognitive loss. However, it significantly helps with sleep, appetite, and emotional calmness. Families note it works best as a supportive layer alongside assessments from neurologists at JCI-accredited hospitals.

Top-rated multi-speciality hospitals for Alzheimer care in India include Kokilaben Dhirubhai Ambani Hospital, Apollo Hospital Indraprastha, and Manipal Hospitals. These JCI-accredited centres feature dedicated memory clinics and full-time neuro-specialists. They also provide integrated geriatric support. These hospitals specialise in cognitive rehabilitation and neuro-imaging for precise Alzheimer diagnosis.

• Dedicated memory clinics: Kokilaben Dhirubhai Ambani Hospital provides specialised speech and behavioural therapy.
• Continuous specialist access: The Full-Time Specialist System provides 24/7 access to neuro-specialists.
• Neuro-imaging: Centres like Apollo Delhi offer precise MRI and CT scans.
• Network reach: Manipal Hospitals treats 2 million patients across 60 specialised departments annually.
• Stem cell research: Some centres explore regenerative approaches alongside standard medication management.

Bookimed Expert Insight: Major networks like Apollo and Manipal dominate the landscape. However, Australian patients should look for the Full-Time Specialist System (FTSS) at Kokilaben Dhirubhai Ambani Hospital. This system ensures doctors are dedicated solely to that facility. This provides better continuity for the long-term cognitive reviews needed for Alzheimer management.

Patient Consensus: Families in India value hospitals offering caregiver education and medication reviews. Patients find that having geriatricians and psychologists in one location makes managing behavioural symptoms much easier.